HomeCompareCCOJF vs MRK

CCOJF vs MRK: Dividend Comparison 2026

CCOJF yields 1.92% · MRK yields 2.81%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 CCOJF wins by $53.56M in total portfolio value· pulled ahead in Year 3
10 years
CCOJF
CCOJF
● Live price
1.92%
Share price
$18.64
Annual div
$0.36
5Y div CAGR
100%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$53.61M
Annual income
$48,731,660.51
Full CCOJF calculator →
MRK
Merck & Co. Inc.
● Live price
2.81%
Share price
$118.10
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$57.7K
Annual income
$10,113.78
Full MRK calculator →

Portfolio growth — CCOJF vs MRK

📍 CCOJF pulled ahead of the other in Year 3

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodCCOJFMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, CCOJF + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
CCOJF pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CCOJF
Annual income on $10K today (after 15% tax)
$163.02/yr
After 10yr DRIP, annual income (after tax)
$41,421,911.43/yr
MRK
Annual income on $10K today (after 15% tax)
$238.95/yr
After 10yr DRIP, annual income (after tax)
$8,596.71/yr
At 15% tax rate, CCOJF beats the other by $41,413,314.72/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CCOJF + MRK for your $10,000?

CCOJF: 50%MRK: 50%
100% MRK50/50100% CCOJF
Portfolio after 10yr
$26.84M
Annual income
$24,370,887.14/yr
Blended yield
90.82%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

CCOJF
No analyst data
Altman Z
2.1
Piotroski
4/9
MRK
Analyst Ratings
24
Buy
12
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+8.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CCOJF buys
0
MRK buys
8
PoliticianChamberTickerTypeAmountDate
Josh Gottheimer🏢 House$MRK▲ Buy$1,001 - $15,0002026-02-04
Michael McCaul🏢 House$MRK▼ Sell$15,001 - $50,0002026-01-13
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-12-19
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-12-18
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-11-13
Ro Khanna🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-29
Val Hoyle🏢 House$MRK▼ Sell$1,001 - $15,0002025-09-23
Marjorie Taylor Greene🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-28
Julie Johnson🏢 House$MRK▼ Sell$1,001 - $15,0002025-08-14
Gilbert Cisneros🏢 House$MRK▲ Buy$1,001 - $15,0002025-08-05
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricCCOJFMRK
Forward yield1.92%2.81%
Annual dividend / share$0.36$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR100%32.7%
Portfolio after 10y$53.61M$57.7K
Annual income after 10y$48,731,660.51$10,113.78
Total dividends collected$53.21M$29.8K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: CCOJF vs MRK ($10,000, DRIP)

YearCCOJF PortfolioCCOJF Income/yrMRK PortfolioMRK Income/yrGap
1$11,084$383.58$11,213$373.04$129.00MRK
2$12,654$794.67$12,667$512.06$13.00MRK
3← crossover$15,236$1,695.84$14,439$708.14+$797.00CCOJF
4$20,119$3,816.47$16,640$988.16+$3.5KCCOJF
5$30,947$9,419.87$19,432$1,394.07+$11.5KCCOJF
6$60,197$27,083.71$23,057$1,992.90+$37.1KCCOJF
7$162,882$98,471.68$27,889$2,894.79+$135.0KCCOJF
8$672,317$498,032.42$34,518$4,286.29+$637.8KCCOJF
9$4,561,788$3,842,409.51$43,912$6,494.35+$4.52MCCOJF
10$53,612,774$48,731,660.51$57,714$10,113.78+$53.56MCCOJF

CCOJF vs MRK: Complete Analysis 2026

CCOJFStock

Coca-Cola Bottlers Japan Holdings Inc., together with its subsidiaries, engages in the purchase, bottling, packaging, distribution, marketing, and sale of carbonated, coffee, tea-based, mineral water, alcohol, and other soft drinks in Japan. The company offers its products under the Coca-Cola, Fanta, Sprite, Real Gold, Georgia, Aquarius, Qoo, Sokenbicha, Huang, and Kochakaden brand names. It also develops, manufactures, and sells various healthcare products; manufacture and sells food products; operates vending machines; and manages beverage sales equipment. In addition, the company provides shared services to support the sales of, nonessential, alcoholic, and dairy beverages, as well as food products; real estate rental and leasing, selling, purchasing, brokerage, and management services; and insurance agency services. It sells its products through convenience stores and vending machines. The company was formerly known as Coca-Cola Bottlers Japan Inc. and changed its name to Coca-Cola Bottlers Japan Holdings Inc. in January 2018. Coca-Cola Bottlers Japan Holdings Inc. was incorporated in 1960 and is headquartered in Tokyo, Japan.

Full CCOJF Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this CCOJF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CCOJF vs SCHDCCOJF vs JEPICCOJF vs OCCOJF vs KOCCOJF vs MAINCCOJF vs JNJCCOJF vs ABBVCCOJF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.